LTRN (Lantern Pharma) OCF Yield %: -40.18 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTRN Lantern Pharma Inc LTRN
33 GF Score
Price $2.98
! 2 Warning Signs
View Full Analysis

What is Lantern Pharma OCF Yield %?

Lantern Pharma LTRN -0.34% 33 OCF Yield % is -40.18 as of Jul. 22, 2026. GuruFocus rates LTRN with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 1,410 Biotechnology companies, Lantern Pharma ranks worse than 80.85% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Lantern Pharma's Trailing 12-Month Cash Flow from Operations is $-15.07 Mil, and Market Cap is $38.02 Mil. Therefore, Lantern Pharma's OCF Yield % for today is -40.18%.

The historical rank and industry rank for Lantern Pharma's OCF Yield % or its related term are showing as below:

LTRN' s OCF Yield % Range Over the Past 10 Years
Min: -41.02   Med: 0   Max: -38.99
Current: -40.18


During the past 8 years, the highest OCF Yield % of Lantern Pharma was -38.99%. The lowest was -41.02%. And the median was %.

LTRN's OCF Yield % is ranked worse than
80.85% of 1410 companies
in the Biotechnology industry
Industry Median: -8.565 vs LTRN: -40.18

Lantern Pharma's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Lantern Pharma OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Lantern Pharma OCF Yield % Related Terms


Lantern Pharma OCF Yield % Historical Data

* Premium members only.

The historical data trend for Lantern Pharma's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantern Pharma OCF Yield % Chart

Lantern Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -11.97 -19.47 -31.27 -51.78 -45.97

Lantern Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.85 -46.21 -38.08 -32.75 -97.88

LTRN vs PDSB, AURX, TIL: OCF Yield % Comparison

For the Biotechnology subindustry, Lantern Pharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lantern Pharma OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lantern Pharma's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Lantern Pharma's OCF Yield % falls into.


LTRN
33GF Score
Lantern Pharma Inc LTRN
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lantern Pharma OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Lantern Pharma's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-15.677 / 34.10265
=-45.97%

Lantern Pharma's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-3.773 * 4 / 15.41935
=-97.88%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -40.18 mean?
Lantern Pharma (LTRN) has a OCF Yield % of -40.18 as of Jul. 22, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Lantern Pharma and its competitors. According to the industry distribution chart, Lantern Pharma ranks #1140 out of 1410 companies in the Biotechnology industry, placing it in the top 80.9%.
Is Lantern Pharma's OCF Yield % too high?
Lantern Pharma's current OCF Yield % is -40.18. Based on the distribution chart, Lantern Pharma ranks #1140 out of 1410 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Lantern Pharma has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Lantern Pharma's OCF Yield % compare to PDSB and AURX?
According to the Biotechnology industry distribution chart, Lantern Pharma ranks #1140 out of 1410 companies for OCF Yield %. This places Lantern Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Lantern Pharma and its competitors. Lantern Pharma's current OCF Yield % is -40.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lantern Pharma stock overvalued right now?
Lantern Pharma (LTRN) has a current OCF Yield % of -40.18. The current OCF Yield % is -40.18. Lantern Pharma's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Lantern Pharma (LTRN), the current OCF Yield % is -40.18 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lantern Pharma Business Description

Address 1920 McKinney Avenue, 7th Floor, Dallas, TX, USA, 75201
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
33GF Score

Get the complete analysis for LTRN

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.98
Price